Sangamo TherapeuticsSGMO
那斯達克 · USD
0.54
0.00
(+0.69%)
盤中 08/02 01:12 (UTC+8)
08/02 01:12 (UTC+8)
Sangamo TherapeuticsSGMO
0.54
0.00
(+0.69%)
財務數據
損益表
- 0.27
- 1.58
- 0.07
- 0.09
- 0.02
- 0.00
- 0.00
- 0.49
- 0.08
- 0.06
- 2.91
- 480.08
- -95.67
- 37.50
- -78.27
- -76.44
- -25.99
- 13779.78
- -84.72
- -14.75
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 6,437 | 7,551 | 49,412 | 356 | 481 | 2,042 | 9,398 | 6,835 | 157,957 | 27,230 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 6,437 | 7,551 | 49,412 | 356 | 481 | 2,042 | 9,398 | 6,835 | 157,957 | 27,230 |
營業費用 | 36,065 | 33,541 | 38,781 | 37,440 | 52,007 | 64,101 | 115,806 | 130,407 | 139,923 | 82,622 |
研發費用 | 26,006 | 23,675 | 27,732 | 24,223 | 35,891 | 50,706 | 57,089 | 63,046 | 63,216 | 66,179 |
推銷及管理費用 | 10,059 | 9,866 | 11,049 | 12,045 | 11,767 | 13,099 | 13,918 | 16,014 | 18,136 | 16,443 |
非經常性項目費用 | - | - | - | 1,172 | 4,349 | 296 | 44,799 | 51,347 | 58,571 | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -29,628 | -25,990 | 10,631 | -37,084 | -51,526 | -62,059 | -106,408 | -123,572 | 18,034 | -55,392 |
其他收入及費用 | -850 | 2,167 | 129 | 1,030 | 2,535 | 1,492 | 3,515 | 2,802 | 3,293 | 3,678 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -30,478 | -23,823 | 10,760 | -36,054 | -48,991 | -60,567 | -102,893 | -120,770 | 21,327 | -51,714 |
所得稅 | 119 | -427 | 88 | 74 | 98 | -272 | 1,270 | -6,264 | 194 | 259 |
稅後純益 | -30,597 | -23,396 | 10,672 | -36,128 | -49,089 | -60,295 | -104,163 | -114,506 | 21,133 | -51,973 |
基本每股稅後盈餘(元) | -0.14 | -0.11 | 0.05 | -0.18 | -0.27 | - | -0.59 | -0.66 | 0.13 | -0.32 |
稀釋每股稅後盈餘(元) | -0.14 | -0.12 | 0.07 | -0.17 | -0.27 | -0.34 | -0.60 | -0.66 | 0.12 | -0.32 |
基本平均股數(千股) | 220269.00 | 210185.00 | 208345.00 | 203946.00 | 180342.00 | - | 177171.00 | 174325.00 | 168533.00 | 164717.00 |
稀釋平均股數(千股) | 220269.00 | 210185.00 | 214325.00 | 203946.00 | 180342.00 | - | 177171.00 | 174325.00 | 169181.00 | 164717.00 |
還原基本每股稅後盈餘(元) | -0.14 | -0.11 | 0.05 | -0.18 | -0.27 | - | -0.59 | -0.66 | 0.13 | -0.32 |
還原稀釋每股稅後盈餘(元) | -0.14 | -0.12 | 0.07 | -0.17 | -0.27 | -0.34 | -0.60 | -0.66 | 0.12 | -0.32 |
還原基本平均股數(千股) | 220,269 | 210,185 | 208,345 | 203,946 | 180,342 | - | 177,171 | 174,325 | 168,533 | 164,717 |
還原稀釋平均股數(千股) | 220,269 | 210,185 | 214,325 | 203,946 | 180,342 | - | 177,171 | 174,325 | 169,181 | 164,717 |
EBITDA(千元) | -28,554 | -21,688 | 12,887 | -33,481 | -46,738 | -57,856 | -95,639 | -115,405 | 25,860 | -47,192 |